Botulinum Toxin A (Botox) for Treatment of Proximal Myofascial Pain in Complex Regional Pain Syndrome: Two Cases

Pain Medicine

Volumn 11, Issue 9, 2010, Pages 1415-1418

  Safarpour, D ^a   Jabbari, Bahman ^a  

^a NONE   (United States)

Author keywords

BoNT A; Botulinum toxin type A; Complex Regional Pain Syndrome (CRPS); Myofascial pain syndrome; Reflex Sympathetic Dystrophy (RSD)

Indexed keywords

BACLOFEN; BOTULINUM TOXIN A; DICLOFENAC; GABAPENTIN; LIDOCAINE; NONSTEROID ANTIINFLAMMATORY AGENT; OXYCODONE; PERCOCET; STEROID;

ADULT; ALLODYNIA; ARTICLE; BACK MUSCLE; CARPAL TUNNEL SYNDROME; CASE REPORT; COMPLEX REGIONAL PAIN SYNDROME TYPE I; DISEASE SEVERITY; EDEMA; FEMALE; FOREARM; FOREARM FRACTURE; HAND; HUMAN; MUSCLE; MYOFASCIAL PAIN; NERVE BLOCK; PAIN ASSESSMENT; QUALITY OF LIFE; RHOMBOID MUSCLE; SKIN ALLERGY; SKIN DISCOLORATION; SPLENIUS CAPITIS MUSCLE; SWELLING; TRAPEZIUS MUSCLE; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE; TRIGGER POINT; VISUAL ANALOG SCALE; WRIST;

EID: 77956537781     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2010.00929.x     Document Type: Article

References (19)

1. Tran De QH, Duong S, Bertini P, Finlayson RJ. Treatment of complex regional pain syndrome: A review of reference. Can J Anesth 2010, 57:149-66.
2. Borenstein DG, Wiesel SW, Boden SD. Neurologica and psychiatric disorders of the spine. Low Back and Neck Pain, Comprehensive Diagnosis and Management 2004, 673-4. Borenstein DG, Wiesel SW, Boden SD. In, eds., Philadelphia, PA, Saunders
3. Fleckenstein J, Zaps D, Ruger LJ. Discrepency between prevalence and perceived effectiveness of treatment methods in myofascial pain syndrome: Results of a cross-sectional, nationwide survey. 2010, 11:32-41.
4. Rashiq S, Galer BS. Proximal myofascial dysfunction in complex regional pain syndrome: A retrospective prevalence study. Clin J Pain 1999, 15:151-3.
5. Argoff CE. A focused review on the use of botulinum toxins for neuropathic pain. Clin J Pain 2002, 18:s177-81.
6. Scott J, Huskisson EC. Graphic representation of pain. Pain 1976, 2:175-84.
7. Evans JA. Reflex sympathetic dystrophy. Surg Gynecol Obstet 1946, 82:36-44.
8. Cummings M, Baldry P. Regional myofascial pain: Diagnosis and management. Best Pract Res Clin Rheumatol 2007, 21:367-87.
9. Wheeler AH. Myofascial pain disorders: Theory to therapy. Drugs 2004, 64:45-62.
10. Ferrante FM, Bearn L, Rothrock R, King L. Evidence against trigger point injection technique for the treatment of cervicothoracic myofascial pain with botulinum toxin type A. Anesthesiology 2005, 103:377-83.
11. Gobel H, Heinze A, Reichel G, Hefter H, Benecke R. Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: Results from a randomized double-blind placebo- controlled multicenter study. Pain 2006, 125:82-8.
12. McMillan AS, Nolan A, Kelly PJ. The efficacy of dry needling and procaine in the treatment of myofascial pain in the jaw muscles. J Orofac Pain 1997, 11:307-14.
13. Hong CZ. Lidocaine injection vs dry needling to myofascial trigger point. The importance of the local twitch response. Am J Phys Med Rehabil 1994, 73:256-63.
14. Garvey TA, Marks MR, Wiesel SW. A prospective, randomized, double-blind evaluation of trigger point injection therapy for low-back pain. Spine 1989, 14:962-4.
15. Graboski CL, Gray DS, Burnham RS. Botulinum toxin A vs bupivacaine trigger point injections for the treatment of myofascial pain syndrome: A randomized double blind crossover study. Pain 2005, 118:170-5.
16. Kamanli A, Kaya A, Ardicoglu O, Ozgocmen S, Zengin FO, Bayik Y. Comparison of lidocaine injection, botulinum toxin injection, and dry needling to trigger points in myofascial pain syndrome. Reumatol Int 2005, 25:604-11.
17. Porta M. A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm. Pain 2000, 85:101-5.
18. Ojala T, Arokoski JP, Partanen J. The effect of small doses of botulinum toxin A on neck-shoulder myofascial pain syndrome. A double-blind, randomized, and controlled crossover trial. Clin J Pain 2006, 22:90-6.
19. Miller D, Richardson D, Eisa M, Baiwa RJ, Jabbari B. Botulinum neurotoxin-A for treatment of refractory neck pain: A randomized, double-blind study. Pain Med 2009, 10:1012-7.